Total Intravenous Versus Inhalational Anesthesia in Patients Undergoing Hip Fracture Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Propofol-based Total Intravenous Anesthesia: Propofol-based total intravenous anesthesia administered according to routine clinical practice during hip fracture surgery.
Sevoflurane-based Inhalational Anesthesia: Sevoflurane-based inhalational anesthesia administered according to routine clinical practice during hip fracture surgery.
Study summary
This prospective observational study aims to compare total intravenous anesthesia (TIVA) with sevoflurane-based inhalational anesthesia in patients aged 65 years and older undergoing hip fracture surgery under general anesthesia. The study will evaluate postoperative quality of recovery using the Quality of Recovery-40 (QoR-40) questionnaire and cognitive outcomes, including postoperative delirium and cognitive status. Pain scores, opioid consumption, recovery room stay, postoperative complications, and patient satisfaction will also be recorded. The anesthesia technique will be determined by the attending anesthesiologist as part of routine clinical practice, and the researchers will not interfere with the choice of anesthesia.
Eligibility
Primary outcome measure(s)
- Quality of Recovery-40 (QoR-40) Score on Postoperative Day 1 — Postoperative day 1
Postoperative quality of recovery will be assessed using the Quality of Recovery-40 (QoR-40) questionnaire. The QoR-40 consists of 40 items evaluating five dimensions of recovery: physical comfort, emotional state, physical independence, psychological support, and pain. Higher total scores indicate better quality of recovery.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital | Istanbul | Istanbul | Recruiting |
More Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07860996 on ClinicalTrials.gov ↗ ← All trials in Turkey